272 related articles for article (PubMed ID: 25629609)
1. Application of the C3-binding motif of streptococcal pyrogenic exotoxin B to protect mice from invasive group a streptococcal infection.
Kuo CF; Tsao N; Cheng MH; Yang HC; Wang YC; Chen YP; Lin KJ
PLoS One; 2015; 10(1):e0117268. PubMed ID: 25629609
[TBL] [Abstract][Full Text] [Related]
2. Determining antibody-binding site of streptococcal pyrogenic exotoxin B to protect mice from group a streptococcus infection.
Tsao N; Cheng MH; Yang HC; Wang YC; Liu YL; Kuo CF
PLoS One; 2013; 8(1):e55028. PubMed ID: 23383045
[TBL] [Abstract][Full Text] [Related]
3. Degradation of complement 3 by streptococcal pyrogenic exotoxin B inhibits complement activation and neutrophil opsonophagocytosis.
Kuo CF; Lin YS; Chuang WJ; Wu JJ; Tsao N
Infect Immun; 2008 Mar; 76(3):1163-9. PubMed ID: 18174338
[TBL] [Abstract][Full Text] [Related]
4. Immunization with a streptococcal multiple-epitope recombinant protein protects mice against invasive group A streptococcal infection.
Kuo CF; Tsao N; Hsieh IC; Lin YS; Wu JJ; Hung YT
PLoS One; 2017; 12(3):e0174464. PubMed ID: 28355251
[TBL] [Abstract][Full Text] [Related]
5. Molecular mimicry between streptococcal pyrogenic exotoxin B and endothelial cells.
Luo YH; Chuang WJ; Wu JJ; Lin MT; Liu CC; Lin PY; Roan JN; Wong TW; Chen YL; Lin YS
Lab Invest; 2010 Oct; 90(10):1492-506. PubMed ID: 20458278
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effects of streptolysin S and streptococcal pyrogenic exotoxin B on the mouse model of group A streptococcal infection.
Hung CH; Tsao N; Zeng YF; Lu SL; Chuan CN; Lin YS; Wu JJ; Kuo CF
Med Microbiol Immunol; 2012 Aug; 201(3):357-69. PubMed ID: 22610375
[TBL] [Abstract][Full Text] [Related]
7. Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection.
Kuo CF; Wu JJ; Lin KY; Tsai PJ; Lee SC; Jin YT; Lei HY; Lin YS
Infect Immun; 1998 Aug; 66(8):3931-5. PubMed ID: 9673282
[TBL] [Abstract][Full Text] [Related]
8. Streptococcal pyrogenic exotoxin A, streptolysin O, exoenzymes, serotype and biotype profiles of Streptococcus pyogenes isolates from patients with toxic shock syndrome and other severe infections.
Müller-Alouf H; Geoffroy C; Geslin P; Bouvet A; Felten A; Günther E; Ozegowski JH; Alouf JE
Zentralbl Bakteriol; 1997 Oct; 286(3):421-33. PubMed ID: 9361388
[TBL] [Abstract][Full Text] [Related]
9. Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus.
Olive C; Ho MF; Dyer J; Lincoln D; Barozzi N; Toth I; Good MF
J Infect Dis; 2006 Jun; 193(12):1666-76. PubMed ID: 16703510
[TBL] [Abstract][Full Text] [Related]
10. Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies.
Mascini EM; Jansze M; Schellekens JF; Musser JM; Faber JA; Verhoef-Verhage LA; Schouls L; van Leeuwen WJ; Verhoef J; van Dijk H
J Infect Dis; 2000 Feb; 181(2):631-8. PubMed ID: 10669348
[TBL] [Abstract][Full Text] [Related]
11. FbaA- and M protein-based multi-epitope vaccine elicits strong protective immune responses against group A streptococcus in mouse model.
Ma C; Liu Z; Li W; Qian X; Zhang S; Gao X; Jiang S; Wei L
Microbes Infect; 2014 May; 16(5):409-18. PubMed ID: 24704476
[TBL] [Abstract][Full Text] [Related]
12. Development of a recombinant fusion protein vaccine formulation to protect against Streptococcus pyogenes.
Morefield G; Touhey G; Lu F; Dunham A; HogenEsch H
Vaccine; 2014 Jun; 32(30):3810-5. PubMed ID: 24837509
[TBL] [Abstract][Full Text] [Related]
13. Streptococcal pyrogenic exotoxin B cleaves human S-adenosylhomocysteine hydrolase and induces hypermethioninemia.
Hsu JF; Chuang WJ; Shiesh SC; Lin YS; Liu CC; Wang CC; Fu TF; Tsai JH; Tsai WL; Huang YJ; Hsieh YH; Wu JJ; Lin MT; Huang W
J Infect Dis; 2008 Aug; 198(3):367-74. PubMed ID: 18522500
[TBL] [Abstract][Full Text] [Related]
14. Active and passive immunizations with the streptococcal esterase Sse protect mice against subcutaneous infection with group A streptococci.
Liu M; Zhu H; Zhang J; Lei B
Infect Immun; 2007 Jul; 75(7):3651-7. PubMed ID: 17502395
[TBL] [Abstract][Full Text] [Related]
15. Identification and assessment of new vaccine candidates for group A streptococcal infections.
McMillan DJ; Batzloff MR; Browning CL; Davies MR; Good MF; Sriprakash KS; Janulczyk R; Rasmussen M
Vaccine; 2004 Jul; 22(21-22):2783-90. PubMed ID: 15246612
[TBL] [Abstract][Full Text] [Related]
16. Histopathologic changes in kidney and liver correlate with streptococcal pyrogenic exotoxin B production in the mouse model of group A streptococcal infection.
Kuo CF; Luo YH; Lin HY; Huang KJ; Wu JJ; Lei HY; Lin MT; Chuang WJ; Liu CC; Jin YT; Lin YS
Microb Pathog; 2004 May; 36(5):273-85. PubMed ID: 15043862
[TBL] [Abstract][Full Text] [Related]
17. Is the nephritogenic antigen in post-streptococcal glomerulonephritis pyrogenic exotoxin B (SPE B) or GAPDH?
Batsford SR; Mezzano S; Mihatsch M; Schiltz E; Rodríguez-Iturbe B
Kidney Int; 2005 Sep; 68(3):1120-9. PubMed ID: 16105042
[TBL] [Abstract][Full Text] [Related]
18. Development of streptococcal pyrogenic exotoxin C vaccine toxoids that are protective in the rabbit model of toxic shock syndrome.
McCormick JK; Tripp TJ; Olmsted SB; Matsuka YV; Gahr PJ; Ohlendorf DH; Schlievert PM
J Immunol; 2000 Aug; 165(4):2306-12. PubMed ID: 10925320
[TBL] [Abstract][Full Text] [Related]
19. Effects of streptococcal pyrogenic exotoxin B on pathogenesis of Streptococcus pyogenes.
Chiang-Ni C; Wu JJ
J Formos Med Assoc; 2008 Sep; 107(9):677-85. PubMed ID: 18796357
[TBL] [Abstract][Full Text] [Related]
20. Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein.
Olive C; Sun HK; Ho MF; Dyer J; Horváth A; Toth I; Good MF
J Infect Dis; 2006 Aug; 194(3):316-24. PubMed ID: 16826479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
